E. Bissagnené

2.0k total citations
87 papers, 1.3k citations indexed

About

E. Bissagnené is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, E. Bissagnené has authored 87 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 37 papers in Epidemiology and 19 papers in Virology. Recurrent topics in E. Bissagnené's work include HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (13 papers). E. Bissagnené is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV Research and Treatment (17 papers) and HIV/AIDS drug development and treatment (13 papers). E. Bissagnené collaborates with scholars based in Ivory Coast, France and United States. E. Bissagnené's co-authors include Xavier Anglaret, Roger Salamon, Raoul Moh, Christine Danel, Delphine Gabillard, Serge Eholié, Amani Anzian, Albert Minga, Eugène Messou and François Dabis and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

E. Bissagnené

81 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Bissagnené Ivory Coast 18 1.0k 545 491 256 123 87 1.3k
Hermann Bussmann United States 23 951 0.9× 634 1.2× 465 0.9× 257 1.0× 73 0.6× 49 1.3k
Kimberly Struble United States 19 1.1k 1.1× 546 1.0× 555 1.1× 201 0.8× 156 1.3× 42 1.5k
Albert Minga Ivory Coast 22 1.1k 1.1× 716 1.3× 547 1.1× 238 0.9× 46 0.4× 62 1.4k
Natasha Press Canada 13 825 0.8× 377 0.7× 431 0.9× 227 0.9× 71 0.6× 25 1.1k
Kenneth A. Freedberg United States 10 1.2k 1.2× 538 1.0× 714 1.5× 242 0.9× 56 0.5× 15 1.5k
Nimâ Machouf Canada 17 802 0.8× 437 0.8× 436 0.9× 222 0.9× 66 0.5× 50 1.1k
Sanay Chearskul Thailand 16 1.1k 1.1× 527 1.0× 578 1.2× 209 0.8× 114 0.9× 42 1.3k
Melissa Krone United States 17 872 0.9× 862 1.6× 566 1.2× 287 1.1× 182 1.5× 25 1.7k
Raoul Moh Ivory Coast 17 821 0.8× 385 0.7× 548 1.1× 245 1.0× 57 0.5× 66 1.1k
George McSherry United States 22 1.6k 1.6× 821 1.5× 765 1.6× 307 1.2× 124 1.0× 52 1.9k

Countries citing papers authored by E. Bissagnené

Since Specialization
Citations

This map shows the geographic impact of E. Bissagnené's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bissagnené with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bissagnené more than expected).

Fields of papers citing papers by E. Bissagnené

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bissagnené. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bissagnené. The network helps show where E. Bissagnené may publish in the future.

Co-authorship network of co-authors of E. Bissagnené

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bissagnené. A scholar is included among the top collaborators of E. Bissagnené based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bissagnené. E. Bissagnené is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touré, Offianan André, Serge-Brice Assi, Koffi Daho Adoubryn, et al.. (2023). Meta-Analysis of Data from Four Clinical Trials in the Ivory Coast Assessing the Efficacy of Two Artemisinin-Based Combination Therapies (Artesunate-Amodiaquine and Artemether-Lumefantrine) between 2009 and 2016. Tropical Medicine and Infectious Disease. 9(1). 10–10. 1 indexed citations
2.
3.
4.
Koné, Daouda, et al.. (2016). Morbidité et mortalité du tétanos des nouveau-nés et des enfants dans les Centres hospitaliers universitaires d’Abidjan, Côte d’Ivoire (2001-2010). Bulletin de la Société de pathologie exotique. 109(3). 172–179. 2 indexed citations
5.
Eholié, Serge Paul, Karine Lacombe, Pauline Campa, et al.. (2015). Metabolic Disorders and Cardiovascular Risk in Treatment-Naive HIV-Infected Patients of Sub-Saharan Origin Starting Antiretrovirals: Impact of Westernized Lifestyle. AIDS Research and Human Retroviruses. 31(4). 384–392. 15 indexed citations
6.
Bissagnené, E., et al.. (2012). Morbidity and mortality from infectious diseases at the Military Hospital of Abidjan, Côte d’Ivoire. Médecine et Santé Tropicales. 22(1). 75–78. 4 indexed citations
7.
Bissagnené, E., et al.. (2012). Surgical tetanus in Abidjan, Cote d’Ivoire. Médecine et Santé Tropicales. 22(3). 279–282. 3 indexed citations
8.
Jaquet, Antoine, Didier Koumavi Ekouévi, Jules Bashi, et al.. (2010). Alcohol use and non‐adherence to antiretroviral therapy in HIV‐infected patients in West Africa. Addiction. 105(8). 1416–1421. 52 indexed citations
9.
Danel, Christine, Delphine Gabillard, André Inwoley, et al.. (2009). Medium-Term Probability of Success of Antiretroviral Treatment after Early Warning Signs of Treatment Failure in West African Adults. AIDS Research and Human Retroviruses. 25(8). 783–793. 7 indexed citations
10.
Adjé-Touré, Christiane, Debra L. Hanson, Marie-Yolande Borget, et al.. (2008). Virologic and Immunologic Response to Antiretroviral Therapy and Predictors of HIV Type 1 Drug Resistance in Children Receiving Treatment in Abidjan, Côte d'Ivoire. AIDS Research and Human Retroviruses. 24(7). 911–917. 41 indexed citations
11.
Danel, Christine, Raoul Moh, Gilles Peytavin, et al.. (2007). Short Communication: Lack of Indinavir-Associated Nephrological Complications in HIV-Infected Adults (Predominantly Women) with High Indinavir Plasma Concentration in Abidjan, Côte d'Ivoire. AIDS Research and Human Retroviruses. 23(1). 62–66. 1 indexed citations
12.
Bissagnené, E., et al.. (2006). Urgences médicales liées au vih/sida en zone tropicale : Étude prospective en Côte d'Ivoire, 1999-2000. 66(2). 162–166. 1 indexed citations
13.
Ehui, E., et al.. (2004). [Morbidity and mortality of tetanus in the infectious and tropical diseases department in Abidjan 1985 - 1998].. PubMed. 97(4). 283–7. 10 indexed citations
14.
Ehui, E., et al.. (2000). Disseminated cryptococcosis revealed by cutaneous manifestations in the course of AIDS.. Journal de Mycologie Médicale. 10(2). 97–99. 4 indexed citations
15.
Bissagnené, E., et al.. (2000). Acquired resistance and prescription of antibiotics in Africa: a critical assessment.. Médecine et Maladies Infectieuses. 30. 4 indexed citations
16.
Eholié, Serge, et al.. (1999). ASPECTS CLINIQUES ET THERAPEUTIQUES DE LA MENINGOENCEPHALITE A TRYPANOSOMA GAMBIENSE EN MILIEU HOSPITALIER. 46(3). 147–152. 1 indexed citations
17.
Bissagnené, E., et al.. (1998). Rhinorrhées et méningites post-traumatiques par une brèche ostéo-mémingée de l'étage antérieur : Aspects cliniques et thérapeutiques : A propos de 8 cas observés à Abidjan. 45. 522–527. 1 indexed citations
18.
Bissagnené, E., et al.. (1997). Profound mycoses with AIDS in Abidjan Ivory Coast. Bulletin de la Société de pathologie exotique. 90(5). 1 indexed citations
19.
Bissagnené, E., et al.. (1992). Ofloxacine dans le traitement de la fièvre typhoïde en milieu hospitalier CHU de Treichville―Abidjan―Côte d'Ivoire. 39(7). 531–534.
20.
Bissagnené, E., et al.. (1987). Principaux aspects du tétanos de l'enfant: influence du PEV, de la sérothérapie intrathécale et des soins intensifs. 21(86). 46–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hermann Bussmann Breakdown of academic impact, for papers by Kimberly Struble Breakdown of academic impact, for papers by Albert Minga Breakdown of academic impact, for papers by Natasha Press Breakdown of academic impact, for papers by Kenneth A. Freedberg Breakdown of academic impact, for papers by Nimâ Machouf Breakdown of academic impact, for papers by Sanay Chearskul Breakdown of academic impact, for papers by Melissa Krone Breakdown of academic impact, for papers by Raoul Moh Breakdown of academic impact, for papers by George McSherry
Rankless by CCL
2026